Bluebird Bio | BLUE - Operating Profit

Bluebird Bio reported $-84781000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Profit Change
Agios Pharmaceuticals AGIO:US USD 28.68M 115.33M
Alnylam Pharmaceuticals ALNY:US USD -188614000 146.01M
Amgen AMGN:US USD 2.23B 508M
Arrowhead Research ARWR:US USD -42134000 41.7M
Avrobio Inc AVRO:US USD -25257000 2.27M
Biogen BIIB:US USD 699.9M 615.2M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Bluebird Bio BLUE:US USD -84781000 22.62M
Gilead Sciences GILD:US USD 2.27B 570M
Immunogen IMGN:US USD -59559000 17.87M
Intercept Pharmaceuticals ICPT:US USD -18024000 83.88M
IONIS PHARMACEUT IONS:US USD -208019000 148.86M
Mirati Therapeutics MRTX:US USD -211723000 25.28M
Moderna Inc MRNA:US USD 1.58B 414M
Nektar Therapeutics NKTR:US USD -52469000 1.83M
Novartis NOVN:VX USD 1.95B 219M
Pfizer PFE:US USD 5.17B 4.24B
Ptc Therapeutics PTCT:US USD -200341000 132.15M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Sangamo Biosciences SGMO:US USD -55392000 498K
Sarepta Therapeutics SRPT:US USD -109408000 147.39M
Seattle Genetics SGEN:US USD -154004000 38.8M
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
Vertex Pharmaceuticals VRTX:US USD 1.03B 93.2M
YTE INCY:US USD 70.09M 68.28M